Back to medications
Medication monograph

bevacizumab

Monoclonal AntibodiesVEGF InhibitorsAntineoplastic AgentsOphthalmic AgentsVascular Endothelial Growth Factor InhibitorChemotherapeutic Agents

Clinical reference

Product monograph

JOBEVNE- bevacizumab-nwgd injection

VEGZELMA- bevacizumab-adcd injection, solution

Brands & formulations

Family members

AVASTIN

Marketed
25 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

MVASI

Marketed
25 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

MVASI

Marketed
25 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

ZIRABEV

Marketed
100 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

ZIRABEV

Marketed
400 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

BAMBEVI

Marketed
100 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

BAMBEVI

Marketed
400 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

ABEVMY

Marketed
400 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

ABEVMY

Marketed
100 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

AYBINTIO

Marketed
100 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

AYBINTIO

Marketed
400 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

VEGZELMA

Marketed
100 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

VEGZELMA

Marketed
400 MGINTRAVENOUSSOLUTION[ "bevacizumab" ]
Product monograph

Classification

Chemical class
Monoclonal Antibodies, VEGF Inhibitors
Clinical class
Antineoplastic Agents, Ophthalmic Agents
Banks class
Vascular Endothelial Growth Factor Inhibitor
AHFS family
Chemotherapeutic Agents